Close Menu

NEW YORK – Exagen said after the close of the market on Tuesday that its third quarter revenues grew 27 percent year over year.

For the three months ended Sept. 30, the San Diego-based company, which went public in September, reported revenues of $10.4 million compared to $8.2 million a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.